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ABSTRACT 
 
Background: Pregnancy and child birth are part of the human development, which is affected by physical, biological, psychological and social 
factors. In pregnant women, maternal physiological state adapts to such an extent that it overcomes problems occurring in pregnancy, but still 
maternal and neonatal mortality and morbidity are seen in present conditions. As new advances in science, technology, research and improved 
socioeconomic status has given new methods and guidelines to control rate of maternal and neonatal mortality. In developing countries 75% 
maternal mortality are those resulting from direct obstetric causes and remaining are due to indirect causes like anemia , cardiac disease ,viral 
hepatitis , etc. In indirect causes, heart disease remains important cause of maternal mortality. Management of heart disease during pregnancy is 
challenging. Thorough knowledge of the expected natural history of the disease during pregnancy and of the possible treatment options is 
required for clinical decision making which will prevent maternal and neonatal complications. Material and Methods: This study was conducted 
in Department of Medicine with the help of Department obstetrics and Gynacology, at JIIU” Indian institute of medical sciences & research” 
Tq.Badnapur, Dist.Jalna.,Maharashtra state, India. From November 2012 to December 2015; consist of 71 women with heart disease in 
pregnancy admitted during the same period in this hospital. The study included both registered and unregistered cases. All pregnant women who 
attended antenatal clinic and found to have heart disease were referred to physician from Department obstetrics and Gynacology. After 
confirmation of diagnosis and grading of heart disease as per NYHA classification all patients were routinely followed with required 
investigation like electrocardiography, echocardiography, and chest radiography. Patients were followed in antenatal clinic regularly. In antenatal 
check-up counseling regarding risk of cardiac disease in pregnancy explained to patients and relatives. All patients detail information taken as per 
study Performa and after all data analyzed in the form of observations and results. Observation & results: Prevalence of heart disease in 
pregnancy was 0.87%. Most of the patients were registered 64 (90.15%) in our hospital or outside hospitals and 9 (9.85%) were totally 
unregistered. At the time of admission 13% cases were diagnosed as case of heart disease in pregnancy first time. Rheumatic heart disease 54 
(76.05%) constituted the commonest type of heart disease. congenital heart disease constituted 11(15.49%) and arrhythmia found in patients 6 
(8.45%).Pure mitral stenosis was found as commonest cardiac lesion in 28 cases out of 54 cases (51.85%) followed by mitral insufficiency in 13 
(24.07%) patients. Out of 11 congenital heart disease patients atrial septal defect  was most common lesion 7(63.63%) followed by ventricular 
septal defect 2 (18.18%), atrioventricular septal defect 1 (9.09%) and Patent ductus artreriosus in 1 (9.09%) case. According to NYHA 
classification we had class I 44 (61.77%) cases, class II 10 (14.08%) cases, class III 9 (12%) cases and class IV 8 (11.26%) cases. The most 
frequent symptom of heart disease in pregnancy was breathlessness 27 (38.02%). followed by cough and palpitations. Anemia and upper 
respiratory tract infection (URTI) remain most common risk factors. We delivered 18 (25.35%) patients by forceps application. LSCS was done 
for obstetric indication and none for cardiac reason. Most common indication for LSCS was fetal distress, followed by cephalopelvic 
disproportion and previous LSCS. Maternal morbidity seen in 30.98% patients. Maternal morbidity in NYHA class III and IV (82%) was six 
times more than in NYHA class I and II (13%). 5 (7%) patients developed CCF, 3 patients had Atrial fibrillation and 10 patients (14.08%) 
developed pulmonary edema. Neonatal outcome by Apgar score was four time better in NYHA class I/II as compare to NYHA class III/IV. 
Neonatal morbidity observed in 55.88% neonates. 27.94% neonates were preterm and 51.47% babies were admitted in NICU after delivery. 
Neonatal morbidity in NYHA class I and II was 56.60% and 64.28% in NYHA class III and IV. Two mothers with congenital heart disease had 
offspring with congenital heart disease. Maternal mortality observed in 4 patients out of 71 patients (5.63%) and neonatal mortality observed in 5 
neonates (7.35%) out of 68 neonates. Out of 4 patients 3 maternal mortality were occurred in antenatal period and in 1 after 4hrs of delivery. All 
4 maternal mortality occurred in NYHA class III and class IV. All four patients had CCF with atrial fibrillation. This maternal mortality were due 
to low socioeconomic status, illiteracy, lack of advanced facility in grass root level, low living standards and ignorance towards female regarding 
health issue. Conclusion: In conclusion, heart disease in pregnancy is associated with significant maternal and perinatal morbidity in NYHA 
class III & IV patients. Rheumatic heart disease was the predominant type. Patients in NYHA class I & II had a better maternal and fetal outcome 
than those in NYHA class III/IV. Surgical correction of the cardiac lesions prior to pregnancy was associated with better pregnancy outcome.  
Pregnancy in women with heart disease is associated with significantly higher maternal morbidity and adverse fetal outcomes and requires a team 
approach for optimal management. 
Keywords: pregnancy with heart disease, Rheumatic heart disease, maternal and neonatal mortality and morbidity, maternal and neonatal 
outcome.   
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Introduction 
 
Pregnancy and child birth are part of the human 
development, which is affected by physical, biological, 
psychological and social factors. In pregnant women, 
maternal physiological state adapts to such an extent that 
it overcomes problems occurring in pregnancy, but still 
maternal and neonatal mortality and morbidity are seen 
in present condition. As new advances in science, 
technology, research and improved socioeconomic status 
has given new methods and guidelines to control rate of 
maternal and neonatal mortality. In developing countries 
75% maternal mortality are those resulting from direct 
obstetric causes and remaining are due to indirect causes 
like anemia , cardiac disease ,viral hepatitis , etc. In 
indirect causes, heart disease remains important cause of 
maternal mortality [1]. In the last quarter of 20th century, 
in the developed countries with high quality preventive 
medicine and improved medical care, surgical correction 
of the congenital lesions and better obstetric care, the 
maternal mortality has reduced markedly [2]. Kung and 
colleagues reported that according to the centers of 
disease control and prevention still heart disease is the 
leading cause of death in women. Cardiac disorders of 
varying severity complicate approximately 1% 
pregnancies and contribute significantly to maternal 
morbidity and mortality rates. The maternal mortality 
rate in developing countries like India is still high due to 
low socioeconomic condition, early marriages; repeated 
pregnancies which induce stress and strain on cardiac 
condition which leads to increase in morbidity and 
mortality due to congestive cardiac failure [3]. In 
developed countries the incidence of rheumatic heart 
disease has drastically reduced and congenital lesions has 
taken over as the leading cause of heart disease[4]. 
Unfortunately developing countries have not managed to 
alter the ratio and rheumatic heart disease continues to be 
the leading cause of heart disease. So heart disease with 
pregnancy should be managed as team approach 
involving an obstetrician and cardiologist and other 
specialists such as anesthesiologist. Every patient should 
have counseling about optimum time to become 
pregnant, the effects of pregnancy on the heart condition, 
the general characteristics of their care during pregnancy, 
the neonatal, perinatal risks. So firm support, consistent 
information and reassurance to the patient are important 
[5].Heart disease in pregnancy also affects the neonatal 
outcome. There is an increased chance of preterm 
delivery, IUGR, neonatal ICU admission. The presence 
of maternal heart disease impacts on the fetus in a 
number of ways [6]. First, the risk of spontaneous 
miscarriage and therapeutic abortion is increased in 
women with heart disease. The offspring of a mother 
with congenital heart disease are also at increased risk of 
inheriting a congenital heart disease [7]. The overall risk 
of the offspring inheriting polygenic cardiac disease is 
quoted as 3 % to 5%, compared with a 1% risk in the 
general population. The risk is, in fact, dependent on the 
affected parent's condition and there is an increased risk 
if a previous sibling has been affected [8].  .Certain 
cardiac medications can adversely affect the fetus. If one 
parent has congenital heart disease the incidence of 
congenital heart disease in offspring increases six fold 
over all [9].Management of heart disease during 
pregnancy is challenging. Thorough knowledge of the 
expected natural history of the disease during pregnancy 
and of the possible treatment options is required for 
clinical decision making which will prevent maternal and 
neonatal complications [10].  
Methods: 
Study design: The study design for our project was a 
hospital based prospective study. This study design was 
selected because it is rapid, inexpensive and easy to carry 
out. This study also allows identification of several 
etiological factors for heart disease in pregnancy and 
their management in neonatal outcome in pregnancy with 
heart disease.  
Aim and Objectives: 
Aim: 
• To Study Maternal And Neonatal Outcome In 
Pregnancy With Heart Disease.   
Objectives: 
• To find out prevalence of pregnancy associated 
with heart disease. . 
• To find out type and grading of heart disease.  
• To study management of pregnancy associated 
with heart disease. 
• To evaluate maternal and neonatal mortality 
and morbidity in pregnancy with heart disease. 
To find out measures to prevent complication 
in pregnancy with heart disease 
Study setting:Study duration: The duration of our 
study was from November 2012 to December 2015. 
Sample size: The sample size was restricted to 71 cases. 
Ethics: The sample of 71 cases was considered to be 
sufficient for this study, which adhered to the principles 
of the Declaration of Helsinki, and was approved by 
independent ethical committees of our college. We 
obtained written informed consent in all cases to 
participate in the study. 
Data collection procedure: All patients who fulfilled 
the inclusion and exclusion criteria were included in this 
study. The consent was taken from the patients or 
attendants who were included in the study, for 
performing the necessary investigations or procedures. A 
Proforma was prepared which included detailed history, 
clinical examination and requisite investigations 
available in our hospital. 
Observations and results 
Table 1: Prevalence of Heart Disease in Pregnancy 
 
Total no. of delivery Total no. delivery  of heart disease patients Prevalence % 
       8140                                   71    0.87% 
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 The prevalence of heart disease in pregnancy in this study was 0.87% .71 cases of heart disease with pregnancy admitted 
during study period. 
Table 2: Registered and unregistered Cases 
 
Groups  No. of patients Percentage of patients 
Registered     Our hospital 44 61.97% 
 Outside hospitals 20 28.16% 
Unregistered 07 09.85% 
 
Thus most of cases were registered either in our hospital or outside hospitals.44 patients from 71cases were registered in our 
hospital and taken regular visits. In registered cases from outside hospital, most of them were referred from primary and 
secondary health care centers for further management.20 patients (28.16%) were registered in outside hospital.7 patients 
were  totally unregistered  came directly in labour. 
 
Table 3: Diagnosed and undiagnosed cases at the time of admission  
Group No. of patients Percentage of patients. 
Diagnosed 62 87.32% 
Undiagnosed 09 12.68% 
 
At a time of admission 9 cases were diagnosed as case of heart disease in pregnancy first time. During clinical examination 
by signs or symptoms patients were diagnosed as heart disease and treated and managed considering only as heart disease 
and latter diagnosis was confirmed by physician consultation and investigations. 
 
Table 4: Age Distribution 
 
         Age (in years) No. of cases       Percentage% 
<20 12 16.90% 
21-25 45 63.38% 
26-30 9 12.67% 
31-35 4 0.56% 
>35 1 0.14% 
 
Maximum numbers of pregnant cardiac patients 45 from 71 (63.38%) were from 21-25 age group. In this study out of 71 
cases12 (17%) patients were from 18-20 age group, 9 (12.67%) from 26-30age group, 4(0.56%) from 31-35 age group, 
1(0.14%) from more than 35 year of age.  
 
Table 5: Distribution of parity 
 
Parity Total No. cases Percentage of patients 
P1 31 43.66% 
P2 27 38.02% 
P3 10 14.08% 
P4 03 4.22% 
Maximum no. of cases admitted during study was primigravida followed by second gravid. In this study 
percentage of patients according to parity were as follow P1-43%, P2-38.02%, P3-14.08%, P4-04.22%. 
 
Table  6 : Etiology Of Cardiac Disease 
 
Type of heart disease Total No. of patients Percentage of patients 
Rheumatic 54 76.05% 
Congenital 11 15.49% 
Arrhythmia 
 
6 08.45% 
Out of all cases 54(76.05%) patients had rheumatic heart disease and 11 (15.49%) patients had congenital heart 
disease and 6 cases had arrhythmia. 
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Table 7:Cardiac Lesions In Rheumatic Heart Disease 
 
Cardiac lesion No. of 
patients 
Percentage of patients 
Mitral stenosis 28 51.85% 
Mitral insufficiency 13 24.07% 
Mitral Stenosis+ mitral insufficiency 4 07.40% 
Mitral valve prolapse (MVP) 3 05.55% 
Aortic stenosis +Mitral stenosis+ Mitral insufficiency 1 01.85% 
Mitral insufficiency +Tricuspid insufficiency 1 01.85% 
Mitral insufficiency +Aortic insufficiency + Tricuspid insufficiency 1 01.85% 
Aortic stenosis +Mitral insufficiency +mitral stenosis 1 01.85% 
Mitral insufficiency +aortic insufficiency 1 01.85% 
Mitral insufficiency +mitral stenosis+Aortic insufficiency 1 01.85% 
 
Mitral valve was most commonly involved in rheumatic heart disease .Mitral stenosis was most common lesion involved in 
28 Cases out of 54 cases of rheumatic heart disease(51.85%) cases. Mitral insufficiency was next common lesion found in 13 
(24.07%) patients.Multiple valve involvement was found in 10 patients in which most of the case presented with signs and 
symptoms of mitral valve involvement. Isolated aortic valve involvement not found but seen with other associated lesions. 
Isolated mitral valve prolapse was found in 3 cases (05.55%).  
 
Table 8: Cardiac Lesions in Congenital Heart Disease 
Cardiac lesion No. of patients Percentage of patients 
Atrial septal defect 7 63.63% 
Ventricular septal defect 2 18.18% 
Patent ductus arteriosus 1 09.09% 
Atrioventricular septal defect 1 09.09% 
 
In congenital heart disease atrial septal defect (ASD) was most common lesion. 7 cases out of 11(63.63%) cases of 
congenital heart disease in pregnancy had ASD. Ventricular septal defect found in 2 cases, atrioventricular septal defect 
found in one case and patent ductus artreriosus in one case. 
 
Table 9: Different types of arrhythmia 
 
Cardiac lesion No. of patients Percentage of patients 
Sinus tachycardia 2 33.33% 
Complete heart block 1 16.66% 
WPW Syndrome 1 16.66% 
RBBB 1 16.66% 
Sinus tachycardia+ LVH 1 16.66% 
 
 In our study 6 patients had arrhythmia especially defect in conduction pathway. Among 6 cases distribution was as follow 1 
case of complete heart block, 3 cases of sinus tachycardia, 1case of RBBB, 1 case of WPW syndrome. 
 
Table 10: Functional Class 
 
 NYHA class No. of cases Percentage of patients 
I  44 61.77% 
II  10 14.08% 
III    9 12.67% 
IV    8 11.26% 
 
 All patients cardiac status was evaluated according to the classification of New York Heart Association. Most of 
them i.e. 54 (76%) among 71 patients belong to either class I or class II. 9 (12.67%) patients were from NYHA class 
III and 8 (11.26%) were belong to NYHA class IV at the time of admission. 
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Table 11: Symptoms presented by the patients 
 
Symptoms  No. cases Percentage 
Breathlessness 27 38.02% 
Palpitation  10 14.02% 
Cough 10 14.08% 
Giddiness 07 09.85% 
Edema over legs 06 08.45% 
Fever 04 05.63% 
Chest pain 03 04.22% 
Hemoptysis 02 02.81% 
Syncope 01 01.40% 
Asymptomatic 27 38.02% 
 
Most common symptom was breathlessness 27(38.02%) followed by cough and palpitations. In this study 27 
(38.02%) patients had no symptoms regarding heart disease. 
 
Table 12: Signs detected in patients 
 
Signs No. of cases Percentage 
Murmur 46 64.78% 
Pallor 17 23.94% 
Tachycardia 13 19.71% 
Bilateral basal rales 10 14.08% 
Arrhythmia 5 07.04% 
Pedal edema 5 07.04% 
Cardiomegaly 5 07.04% 
Wheeze 2 02.81% 
Cyanosis 1 1.40% 
Bradycardia 1 1.40% 
 
Most of the cases were diagnosed by presence of murmur on auscultation .46 (65%) patients presented with 
characteristic murmur of particular lesion on auscultation. Bilateral crepitation was present in 10(14.08%) patients on 
auscultation suggestive of pulmonary edema .Tachycardia was present in 13 cases and bradycardia was in 1 case. 
Cyanosis was present in single case. ECG changes showing irregular heart rate and pulse were present in 5 cases. 
Cardiomegaly was present in 5 cases on clinical and radiographic findings. 
Table 13: Associated Risk Factors 
 
Medical and obstetrical risk factor No. of cases   Percentage 
Anemia 17 23.94% 
URTI 11 15.49% 
Pregnancy induced hypertension 04 05.63% 
Twins 03 04.22% 
Breech 02 02.81% 
In this study anemia and upper respiratory tract infection (URTI) remain most common risk factors .Anemia was present in 
around 24% patients and URTI found in 11(15.49%) patients.3 cases of twins and 2 cases of breech were seen in this study. 
 
Table 14: Surgery for cardiac pathology 
Name of surgery    No. of patients 
Pre-pregnancy valvotomy 03 
ASD Closure 03 
Pacemaker implantation 01 
Radio ablation 01 
Angioplasty 01 
3 patients of severe mitral stenosis underwent balloon mitral valvotomy before pregnancy. 3 patients were operated for 
septal defect correction surgery before conception. For WPW Syndrome in 1 patient radio ablation was done. Angioplasty 
was done in one patient for cardiac ischemia before conception.  
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Table 15: Medications used in heart disease in pregnancy 
 
Name of medicine No. of cases Percentage 
Diuretics 10 14.08% 
Digoxin 06 08.45% 
Beta- blocker 03 04.22% 
 
Digitalis therapy used in 6 patients for management of CCF. T.Digoxin used as digitalis preparation. Diuretics were used in 
10 patients for management of pulmonary edema and congestive cardiac failure. Beta blocker used in 3 patients as to control 
heart rate and arrhythmia. 
 
Table 16: Duration of pregnancy at the onset of labour 
 
Duration of gestation No. of cases  Percentage 
  <32 WKS  12 16.90% 
32-36 WKS 13 18.30% 
37-42 WKS  46 64.78% 
  >42 WKS 00 - 
 
Maximum patients were full term from 37-42 wks (65%).preterm onset of labour were present in 25 (35%) cases.  
 
Table 17:Mode of delivery 
    Mode of delivery No. of cases percentage% 
1)Vaginal 34 47.88% 
            Forceps 18 25.35% 
           Full term vaginal 08 11.26% 
           Preterm vaginal  07 09.85% 
           Ventouse 01 01.40% 
2)LSCS 32 45.07% 
3)Abortion 02 02.81% 
4)Not delivered 03 04.22% 
 
Out of 71 patients 34 (11.26%) patients delivered  vaginal delivery. 18 babies delivered by forceps application for cut short 
second stage of labour and 1 delivered by ventouse application.8 patient had full term vaginal delivery and 7 had preterm 
vaginal delivery. LSCS was done in 32 cases (45.07%). Abortion happened in 2 cases. In 07 (09.85%) cases preterm vaginal 
delivery happened.  
 
Table 18: Indications of LSCS 
 
Indication   Total  no. cases 
Fetal distress 11 
Cephalopelvic disproportion 07 
Previous LSCS with associated indication 07 
Failure of progression of labour 02 
Malpresentation 02 
Placenta previa 02 
Abruption of placenta 01 
 
Most common indication for LSCS was fetal distress, followed by cephalopelvic disproportion. 
 
Table 19: Maternal morbidity 
 
Morbidity No of cases Percentage of patients 
Congestive cardiac failure 05 07.04% 
Atrial fibrillation 03 04.22% 
Pulmonary edema 10 14.08% 
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Deterioration of NYHA class 09 12.67% 
In this study 5 (7%) patients developed CCF, 3 patients had atrial fibrillation, and 10(14.08%) patients developed pulmonary 
edema. Worsening of NYHA class by >2 classes occurred in 9 of 71(12.67%)pregnancies in which baseline NYHA class 
was I or II.42 cases of 71 were without any maternal morbidity. 
  
Table 20: Neonatal assessment by Apgar score 
 
APGAR  score No. of neonates Percentage of neonates  
At 1 min. At 5min. At 1min.  At 5min. 
0-4 10 03 14.70% 04.41% 
5-7 08 05 11.76% 07.35% 
8-10 50 60 73.52% 88.23% 
 
In this study 73.52% babies had APGAR score above 8 and 15% babies had APGAR less than 4 at the time of birth, at1 min. 
At 5 min APGAR score, only 3 babies had APGAR less than 4 and 60 babies (88%) had APGAR >8. 
 
Table 21: Neonatal assessment by weight 
 
Weight in kg No. of neonates Percentage of neonates 
<1.5  08 11.76% 
1.6-2.0 06 08.82% 
2.1-2.5 22 32.35% 
2.6-3.0 18 26.47% 
3.1-3.5 13 19.11% 
>3.6 01 01.47% 
 
 In fetal assessment by weight, most of the babies 32.35% were from 2.1-2.5 kg group.36 babies from low birth weight 
group.8 babies from very low birth weight. 1 baby had extremely low birth weight.  
Table 22: Neonatal morbidity 
 
Cause No. of cases Percentage of neonates 
NICU admission 35 51.47% 
Prematurity 19 27.94% 
 Neonatal jaundice  08 11.76% 
Small for gestational age 06 08.82% 
Neonatal hypoglycemia 06 08.82% 
Neonatal sepsis 05 07.35% 
Meconium aspiration syndrome  05 07.35% 
Respiratory distress  05 07.35% 
Congenital anomalies 03 04.41% 
 
 In this study out of 71 cases 65 patients had given live birth to 68 babies in whom three patients had twin pregnancy and one 
baby stillbirth. Neonatal morbidity observed in 38 babies out of 68 neonates (55.88%). 35 babies were admitted in NICU 
after delivery (51.47%). 19 out of 68 live births were preterm (27.94%).6 babies were small for gestational age (08.82%). In 
3 babies congenital anomaly were found, 1 baby had ectopia cardis and 2 babies had ASD. So in this study 2 mothers with 
congenital heart disease had offspring with congenital heart disease. 10 cases of RDS and meconium aspiration were seen. In 
NICU admissions 8 babies had neonatal jaundice, 6 babies had neonatal hypoglycemia and 5 neonates had neonatal sepsis.  
 
Table 23: Perinatal and maternal mortality 
Mortality Total no of mortality / Total no of cases Percentage  
Maternal mortality  
 
                   4 /71 05.63% 
Perinatal mortality                      5/68 07.35% 
In this study maternal mortality observed in 5.63% patients and neonatal mortality observed in 7.35% neonates. 
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Table 24: Contraceptive advice 
Contraceptive No. of cases percentage 
Barrier 48 71.64% 
IUCD 02 2.98% 
Tubal ligation done 02 2.98% 
Sterilization advice 
a)Tubectomy/Vasectomy 
b)Vasectomy only 
16 
12 
04 
23.88% 
17.91% 
05.97% 
 
 Contraceptive advice was given to 67 patients. Tubal ligation was done in 2 patients during LSCS.  Vasectomy advised to 
4 patients due to maternal high risk cardiac status and high risk in operative procedure. 
 
Discussion 
Pregnancy and peripartum period are associated with 
important cardio- circulatory changes that can lead to 
marked clinical deterioration in the women with heart 
disease. However, women who receive adequate 
antenatal care generally fare well and have favorable 
maternal as well as neonatal outcome. Lang and 
Borrow [83] (1985) reported that during pregnancy and 
labour, significant hemodynamic changes have been 
observed which are tolerated well by most healthy 
women. Sullivan and Ramanathan[126](1985) said that 
an additional strain is caused in cardiovascular system of 
mother during pregnancy if they suffer from organic 
heart disease, leading to high morbidity in them. It is 
natural to expect that the fetus also would be 
compromised in these mothers especially in presence of 
cardiac decompensation. With improving facilities for 
diagnosing and evaluating cardiac disorder, pregnancy 
with its tremendous cardiovascular implication is no 
longer the ominously hazardous condition that it used to 
be in the past. Early identification, better stabilization, 
intensive monitoring and prompt management of any 
complication have all greatly contributed in reducing the 
morbidity and mortality from this serious disorder. The 
present study aimed at analyzing the prevalence, 
etiology, management, complication and outcome of 
heart disease in pregnancy. The study includes 71 
pregnant cardiac patients out of total 8140 admissions 
who delivered during a 3 year study period. The aim of 
present study is to evaluate maternal and neonatal 
outcome in pregnancy with heart disease at tertiary 
health care center. 
Prevalence of pregnancy with heart disease: The 
present study has shown 0.87% prevalence of pregnancy 
with heart disease in our hospital admissions. As shown 
in table no.1, out of 8140 delivered patient 71 patient had 
heart disease. 
 
Table 25: Prevalence of pregnancy with heart disease 
 
Name of Author  Year Prevalence 
Deshmukh and coworkers 1979 0.55% 
Pinto rosaria and coworkers  1979 0.15% 
Rush and coworkers 1979 0.46% 
De swiet and coworker 1981 0.5-1.8% 
C.B.Purendare and Daftary    1984 0.29% 
Malhotra and coworkers  2000 1% 
Sawhney .H and coworkers   2003 1.20% 
Doshi HU and coworkers  2010 1.00% 
In present study 2011 0.87% 
 
The reported prevalence of heart disease with pregnancy 
is 0.2 to 3.6% in Indian study. Prevalence varies with 
different workers; it varies with geographical location, 
seasons and incidence of rheumatic fever like prevalence 
is more in developing country as compare to developed 
country. Prevalence rate in different countries as follow 
in USA it is 1-3%, in London 0.5 to 1.8%, in South 
Africa o.8%. The prevalence of pregnancy with heart 
disease at our hospital is in same range as compared to 
other authors as shown in Table 26 
Registered and Unregistered cases: In our study most 
of cases were registered either in our hospital or outside 
hospitals. As shown in table No.2, 44 patients from 71 
cases were registered in our hospital and taken regular 
visits. In registered cases from outside hospitals, most of 
them were referred from primary and secondary health 
centers for further management. 20 patients (28.16%) 
were registered in outside hospital. In present study 7 
Patients were totally unregistered came directly in 
labour. Thus most of our patients were diagnosed cardiac 
patients. Most of them were under treatment by 
cardiologist before & for pregnancy. Due to better 
awareness and increased use of available facilities 
enabled these patients to go through the pregnancy 
smoothly. But still 7 patients out of 71 (10%) patients 
were not registered with any hospital and they were 
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unaware regarding risk associated with heart disease and 
this is most common cause for morbidity and mortality in 
developing country. Maternal mortality reported in 2 
cases out of 7(28%)  unregistered cases. which is nine 
times higher compare with mortality in booked cases 
(3%) in pregnancy with heart disease. Reasons behind 
this high rate of mortality are different as low 
socioeconomic status, illiteracy, lack of advanced facility 
in grass root level, low living standards and ignorance 
towards females regarding health issue. Also maternal 
and neonatal outcome is better in registered cases as 
compared with unregistered cases. 
 Diagnosed and Undiagnosed cases at the time of 
admission: At a time of admission 9(12.68%) cases were 
diagnosed as case of heart disease in pregnancy first time 
(table no 3). During clinical examination by its signs and 
symptoms like, dyspnea, palpitation, chest pain, diastolic 
murmur, systolic murmur of IV-V grade patient 
diagnosed as heart disease patient first time. Then 
diagnosis is confirmed by doing investigation and 
physician consultation. So in heart disease patients 
clinical examination have important role in diagnosis and 
management. Merz WM and colleagues[94](2010) 
reported that 14.3% women presented with first 
manifestation of heart disease in pregnancy and 85.7% 
women had pre-existing cardiac condition.                    
Age Distribution: Majority of pregnant cardiac patients 
in our study were from age group of 21 to 30 years 
(75%) as it is commonest age group for pregnancy. 
Daftary et al [38] (1986) at Bombay reported that 75% 
of the patients in the age group of 20 to 29 years. 
Swarajya et al[129] (1995) reported that 71% of the 
cases were in the age group of 21- 30 years. As shown in 
table no.4. In present study 12 (16.90%) patients were 
from < 20 year of age, 4 patients were from age group 
31-35 years. One patient’s age was 40 year.    
Parity Distribution: Present study primiparas and 2nd 
paras together formed 81% of the patients. Only 18% of 
the patients were from Parity 3 and 4. Maximum no. of 
cases admitted during study was primigravida followed 
by second gravida. In this study percentages of patients 
observed according to parity were as follow P1-43%, P2-
38.02%, P3-14.08%, P4-04.22 %.( table no.5).Sui sc and 
colleagues [120] reported 2001 heart disease in 58% 
primigravida 1% in multipara. So still awareness 
regarding complication due to heart disease in pregnancy 
and multiparity is needed in society 
Types of cardiac disease: (Table No. 6) In our series 
analysis of the types of cardiac pathology showed 
preponderance of rheumatic heart disease. Rheumatic 
heart disease seen in 54 patients out of 71 
patients(76.05%), congenital heart disease in 11( 
15.49%) patients and arrhythmia in 6 patients (8.45%). 
Most of the studies in pregnancy with heart disease have 
reported that rheumatic fever forms the major cause of 
heart disease. The following data shows etiology and 
percentages with other authors. 
 
Table 26: Data showing etiology and percentages with other authors 
 
Author’s name      Year    RHD CHD 
Siu s. and colleagues      2001       22% 74% 
Hameed A and colleagues      2001       90% 10% 
Agrawal and colleagues      2003       63% 27% 
stangl and colleagues      2008          10.80% 81% 
Doshi HU and colleagues      2010   68.62% 21.57% 
Merz WM  and colleagues      2011   18.40% 53.10%            
In present study     2011 76.05% 15.49% 
 
The prevalence of etiology varies considerably between 
countries and strongly related with socioeconomic 
condition. Now since last decade incidence of pregnancy 
with congenital heart disease is increased as compared 
with rheumatic heart disease in developed countries. This 
is secondary to improvement in diagnostic, surgical and 
medical techniques, which in turn have resulted in more 
women with congenital heart disease reaching Up to 
Child bearing age. However in India rheumatic heart 
disease still accounts for the majority of cardiac lesion 
detected during pregnancy. In Indian 
study[56]prevalence of rheumatic heart disease is as 
follow, Devi and subhadra 1997 -87.8%, Punjabi 1996- 
83%, Parvathi and Anjanyelu 1976- 90%, Sidar 1980-
93.2%, chadha and colleagues 1981-90.3%, allahbadia 
and colleagues 1989-88%. So in present study prevalence 
of rheumatic heart disease in pregnancy was slightly 
reduced and that may be good sign indicating 
improvement in health status of society in last decade. 
Cardiac Lesions in rheumatic heart disease: (Table 
No.7)Rheumatic heart disease is still the major cause of 
heart disease in pregnancy. Mitral stenosis is the 
commonest cardiac lesion. In our series pure mitral 
stenosis constituted in 28(51.85%) patients out of 54 
patients of RHD & 24.07% were of mitral incompetence. 
Multiple valve involvement was found in 10 patients. 
Combined mitral stenosis and mitral incompetence 
reported in 4 (7.40%) patients. Purely isolated aortic 
stenosis and aortic regurgitation not found but associated 
with mitral valve lesion found. So in all cases mitral 
valve involvement observed. Hameed A and 
colleagues[64](2001) found dominant mitral stenosis in 
90% patients, mitral incompetence in 6.6%, aortic 
incompetence in 2.5%, and aortic stenosis in 3%. 
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Table 27: Authors with respect to their AS, MS, MI, AR in respective years 
 
Authors’ name Year MS MI AS AR 
Hameed A and colleague 2001 90% 7% 3% 2.50% 
Stangl and colleagues 2008 50.00% 12% 17.10% 5.30% 
Doshi HU and colleagues 2010 80.00% 12.00% _ _ 
In present study 2011 51.85% 24.07% 1.85% 1.85% 
 
Cardiac lesions in congenital heart disease: In this 
study in congenital heart disease atrial septal defect 
(ASD) was most common lesion. 7 cases out of 
11(63.63%) cases of congenital heart disease in 
pregnancy had ASD. Ventricular septal defect found in 2 
cases, atrioventricular septal defect found in one case and 
Patent ductus artreriosus in one case (Table no. 8).  
These observations are equivalent with other studies. 
Malhotra M and colleagues [90] (2003) reported ASD 
were more common in congenital heart disease.  Varena 
stangle and colleagues [124] (2008) reported prevalence 
of different cardiac lesion as follow ASD in 9.2%, VSD 
in 10.5%, atrioventricular septal defect in 5.3%, 
Transposition of great vessels 2.6%, TOF in 9.2%, 
ebstein anomaly in 3.9%. Devabhaktuni pratibha and 
colleagues [45] (2010) reported ASD -29.46%, VSD- 
25%, PDA- 6.25% TOF-2.68%. 
 Different types of arrhythmia: In present study 6 
patients had arrhythmia especially defect in conduction 
pathway. Among 6 cases distribution was as follow 1 
case of complete heart block, 3 cases of sinus 
tachycardia, 1case of RBBB, 1 case of WPW syndrome 
(Table no.9). Merz WM  and colleagues [94] (2011) 
reported 16.3% prevalence of arrhythmia in their study.  
Premature extra beats and sustained tachyarrhythmia’s 
become more frequent and may even manifest for the 
first time during pregnancy. Symptomatic exacerbation 
of paroxysmal supraventricular tachycardia (SVT) occurs 
during pregnancy in 20 to 44% of cases. 
Grading of heart disease: In our study 76% of the 
patients were compensated so they were either in 
functional class I or class II. 9 (12%) patients were in 
class III, 8(11%) patients were in functional class IV 
(table no10), so our series most of them were 
compensated. This is because of early detection, good 
antenatal follow-up and good awareness among patients 
themselves. Siu s. and colleagues[120] (2001) reported 
that the risk of pulmonary edema, sustained arrhythmias, 
strokes, cardiac arrest, CCF, death was substantively 
increase with NYHA class III or IV. He reported 
19%pregnancies complicated by pulmonary edema 
occurred in women with baseline NYHA class III. 
Maternal morbidity and maternal mortality was high in 
class III & IV as compared to class II and I. 4 maternal 
deaths reported during present study was from NYHA 
class IV. In this study 7 out of 10(70%) case of 
pulmonary edema, all 5(100%) cases of congestive 
cardiac failure, all 3(100%) case of atrial fibrillation were 
from NYHA class III and IV.  
 Bhatla N and colleagues [16]  (2003) reported patients 
in NYHA class I/II (n=175, 84.54%) had fewer maternal 
complications and their babies had a higher birth weight 
than those in NYHA class III/IV (n=32, 15.45%). Doshi 
HU and colleagues [48] (2010) reported that cardiac 
complications developed in 17.02% of the women, most 
common being congestive cardiac failure. It was found 
more in New York Heart Association grades III and IV. 
In this present study maternal morbidity observed in 7 
patients out of 54 (13%) patient of NYHA class I and II 
and neonatal morbidity was present in 30 out of 53 
(56.60%) neonates of mother from NYHA class I and II. 
In NYHA class III and IV maternal morbidity was 
present in 14 cases out of 17(82%) patients and neonatal 
morbidity was present in 9 neonates out of 14(64.28%) 
neonates. 
Symptoms and signs presented by the patients: 
The         most frequent symptom of heart disease in pregnancy is 
breathlessness. In this study most common symptom 
was breathlessness 27(38.02%) followed by cough and 
palpitations (Table no.11). In this study 27(38.02%) 
patients had no symptoms regarding heart disease. 
Wood P. reported [144] in 1954 that patients of mitral 
stenosis present with fatigue, dyspnea, or frank 
pulmonary edema, in others, the initial manifestation of 
MS is the onset of atrial fibrillation or an embolic event. 
Jessup and Brozena[75] (2003) said that first warning 
sign is likely to be persistent basilar rales, frequently 
accompanied by a nocturnal cough. A sudden diminution 
in ability to carry out usual duties, increasing dyspnea on 
exertion, or attacks of smothering with cough is 
symptoms of serious heart failure. In this study bilateral 
basilar rales were present in 10 (14.08%) patients on 
auscultation suggestive of pulmonary edema (table 
no.12). Leatham A. [84] 1958 described that cardiac 
auscultation remains the most widely used method of 
screening for heart disease. Shaver JA [115] (1995) said 
that most systolic heart murmurs do not signify cardiac 
disease, and many are related to physiological increases 
in blood flow velocity. In other instances, a heart 
murmur may be an important clue to the diagnosis of 
undetected cardiac disease (e.g., valvular aortic stenosis) 
that may be important even when asymptomatic or that 
may define the reason for cardiac symptoms. Diastolic 
murmurs virtually always represent pathological 
conditions and require further cardiac evaluation. In this 
study most of cases were diagnosed by presence of 
murmur on auscultation .46 (65%) patients presented 
with characteristic murmur of particular lesion on 
auscultation (table no.12). Silversides CK and 
colleagues [73] (2006) reported that premature extra 
beats and sustained tachyarrhythmia’s become more 
frequent and may even manifest for the first time during 
pregnancy. Symptomatic exacerbation of paroxysmal 
supraventricular tachycardia (SVT) occurs during 
pregnancy in 20–44% of cases. In this study tachycardia 
was present in 13 cases and bradycardia was present in 1 
case [19.1%]. Samule c. Siu and colleagues [120] 
(2001) reported cyanosis is one of the predictor of risk in 
pregnancy with heart disease in cardiac, neonatal and 
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postpartum haemorrhage. In our study 1 patient had 
cyanosis and maternal mortality reported in same patient 
Associated co-morbidities:In our study anemia and 
upper respiratory tract infection (URTI) remain most 
common risk factors .Anemia was present in17 patients 
(24%) and URTI found in 11(15%) patients( table 
no13).3 cases of twin pregnancy and 2 cases of breech 
presentation were seen in study. Anemia was present in 
17 cases out of 71 patients, out of this 17 cases 4 patients 
required blood transfusion other patients were managed 
with oral iron preparation. To all patients with URTI 
antibiotic course were given. Anemia in pregnancy 
mimic like heart disease so while evaluating patient 
precaution was taken. Anemia increases cardiac 
workload and should be avoided by regular use of 
hematinics. Prognosis in cardiac diseases worsens when 
it is complicated by anemia, where the hyperdyanamic 
circulation puts more load on the already damaged heart. 
William N.P, Gregory A.L [142] reported that anemia 
is a common problem in pregnancy and should be 
avoided in the patient with cardiac disease through the 
judicious use of iron, prenatal vitamins, and dietary 
counseling. In present study among four maternal 
mortality cases one had severe anemia which worsen 
preexisting cardiac failure and one patient had URTI 
which was trigger factor for cardiac failure. 
Surgery for cardiac pathology: Early experience with 
balloon valvotomy as published by Palacios (1987) and 
Mckay et al [93] (1987) has been favorable for the 
treatment of pregnant patients with severe mitral 
stenosis. The other advantages of this technique is 
decrease in morbidity, avoidance of anesthesia and risk 
associated, fast recovery and short hospital stay. In our 
study 3 patients of severe mitral stenosis underwent 
balloon mitral valvotomy before pregnancy (Table 
No.14). Out of 3 patients 2 patients are from NYHA 
class III and deterioration of NYHA class reported, 
LSCS done in 2 for obstetrical indication and 1 patient 
went in preterm labour. M. Malhotra and 
colleagues[90](2003) reported that mitral valve surgery 
before or during pregnancy did not significantly improve 
maternal and fetal outcomes but decreased adverse 
events such as congestive heart failure and cardiac 
arrhythmias. Datta Ray Chaitali and colleagues[40] 
(2004) reported that there were statistically significant 
differences in the period of gestation attained, mode of 
delivery and post-delivery hospital stay but differences in 
weight of the babies and Apgar scores were not 
significant. The prognosis improved after surgery. 
Mortality was more in the non-operated group. Therefore 
it should be performed only in selected cases. As we had 
only three patients who underwent cardiac surgery, so 
conclusion regarding its advantage could not be made.  3 
patients out of 7 patients of ASD underwent through 
closure of primary lesion of septal defect. Mark 
maberry [91] (1989) quotes that the frequency of 
congenital heart disease encountered during pregnancy 
has increased over the last two decades. This is 
secondary to improvement in diagnostic, surgical and 
medical techniques, which in turn have resulted in more 
women with congenital heart disease reaching up to 
Child bearing age. All three patients were from NYHA 
class I and no maternal mortality and morbidity reported 
except one operated patient had 8 wks abortion. So in 
operated cases maternal and neonatal outcome in present 
study was better as compared to non -operated cases.  
Medications used in heart disease in pregnancy. 
 Digitalis therapy used in 6 patients for management of 
CCF. T.Digoxin used as digitalis preparation. It started 
with loading dose of 1-1.5mg in 24 hrs period and 
maintenance dose as 0.25mg daily. Diuretic frusemide 
was used in 10 patients for management of pulmonary 
edema and congestive cardiac failure (table no16). 
Intravenous dose of frusemide started initially as 40 mg 
and dose adjusted with B.P., urine output and clinical 
findings. Beta blocker used in 3 patients as to control 
heart rate and arrhythmia. In the DIG trial [117] 1997 
said that digoxin therapy was most beneficial in patients 
with ejection fractions of 25 % or lower, patients with 
enlarged hearts (cardiothoracic ratio of greater than 0.55) 
and patients in NYHA functional class III or IV. The 
findings of the DIG trial also indicated that digoxin was 
clinically beneficial in subgroups of patients with less 
severe forms of heart failure. Agents with negative 
chronotropic properties such as B-blockers or calcium 
channel blockers may be of benefit in patients in sinus 
rhythm who have exertion symptoms and if these 
symptoms occur with high heart rates. Blomstrom-
Lundqvist C and colleagues [119] (2004) said that 
digoxin or selective β-blocking agents (metoprolol) are 
the first-line agents in management of supraventricular 
tachycardia. Showkat a and colleagues[120] (2000)  
reported that  the goal of digoxin therapy in patients with 
congestive heart failure is to improve quality of life by 
reducing symptoms and preventing hospitalizations. In 
this study diuretics were used in 10 patients as 
management of CCF. Devabhaktuni P. and colleagues 
[45] (2010) reported in their study that 18 women 
(16.07%) were on tablet Digoxin 0.25 mg; 6 (5.36%) 
were on diuretics. 
Duration of pregnancy at onset of labour: Maximum 
patients were full term from 37-42 wks (65%).preterm 
onset of labour were present in 25 (35%) cases (Table 
No.16). 42 patients out of 71 were from 37 to 42 wks of 
gestation. Merz WM M [94] and coworker found that 
mean gestational age at delivery was 36+6 wks in there 
study. Datta Ray Chaitali and coworker [40] 2004 said 
that the mean period of gestation attained at delivery in 
the operated group was 37.9 ± 1.96 weeks while in the 
nonoperated group it was only 36.3 ± 4.59 weeks. In this 
study mean gestational age at delivery was 35 ±3 weeks 
which corresponds with other study. 
Mode of delivery: Out of 71 patients 34 (47.88%) 
patients delivered  vaginaly. 18 babies delivered by 
forceps application to cut short second stage of labour 
and 1 delivered by ventouse application.8 patient had full 
term vaginal delivery and 7 had preterm vaginal delivery. 
LSCS was done in 32 cases (45.07%). Abortion 
happened in 2 cases. While three patients died 
undelivered. Datta Ray Chaitali and coworker [40] 
(2004) reported that in the operated group prevalence of 
lower segment cesarean section (LSCS) was 82%. While 
in the nonoperated group it was only 57% (25/44). 
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Table 28: Authors with respect to their LSCS 
 
Author’s name/ Year   LSCS     Vaginal 
Samule c Siu and colleagues      2001       27%     73% 
Devabhaktuni P. and colleague 2010  37.61% 62.39% 
Doshi HU and colleagues            2010 31.91% 68.08% 
Merz WM M and colleagues         2011 77.50% 22.50% 
In present study 45.0 47.48% 
 
We had 18 deliveries (25.35%) by forceps 
application as maternal indication to cut short 
second stage of labour. Devabhaktuni P. and 
colleagues [45] (2010) reported 9.17% rate of 
forceps application. In our study percentage of 
LSCS is on higher side as compared with other 
study. In most of cases epidural or general 
anesthesia was preferred. Christopher James et al 
[31] (1992) states that for caesarean section 
delivery, lumbar epidural anesthesia in indicated 
for patients with mild mitral stenosis. General 
anesthesia may be the preferred method for patients 
with severe mitral stenosis as long as drugs that 
induce tachycardia are avoided like ketamine, 
pancuronium and anticholinergics. 
 Indications of LSCS: In all 32 cases LSCS was 
done for obstetric indication and none for cardiac 
reason. Most common indication for LSCS was 
fetal distress, followed by cephalopelvic 
disproportion and previous LSCS (table no.18). 
Samule c Siu and colleagues [120] (2001) 
reported that in their study 96% caesarean 
deliveries were for obstetric indications, cardiac 
status was the indication in 4%. Merz and 
colleagues [94] (2011) reported that the LSCS rate 
was 77.5% and 31.6% were performed for cardiac 
lesion. 
Maternal morbidity in pregnancy with heart 
disease: In this study 5 (7%) patients developed 
CCF, 3 patients had atrial fibrillation and 10 
patients (14.08%) developed pulmonary edema. 
Worsening of NYHA class by >2 classes occurred 
in  9 of 71(12.67%)pregnancies in which baseline 
NYHA class was I or II.42 cases were without any 
maternal morbidity(table no.19). Maternal 
morbidity seen in 22 cases out of 71 cases so 
maternal morbidity in this study was 30.98%. 
Maternal morbidity in NYHA class III and IV is 
more than in NYHA class I and II. In this study 
maternal morbidity was present in 7 patients out of 
54 (13%) patient of NYHA class I and II and in 
NYHA class III and IV maternal morbidity was 
present in 14 cases out of 17(82%) patients. 
 
Table 29: Authors with respect maternal morbidity 
 
Name /Year    Maternal Morbidity 
Samule c. SIU and colleagues 2001                      13.00% 
Doshi HU and colleagues 2010                      17.02% 
Bhatla n and colleagues 2003                       29.95% 
In present study                      30.98% 
       
        In this study congestive cardiac failure occurred in 5 
cases all are from NYHA class III and IV. In 3 patients 
CCF was associated with atrial flutter and pulmonary 
edema and maternal mortality occurred in these three 
patients. One patient of CCF responded to medical 
management with digoxin and diuretics. Pulmonary 
edema was documented by chest radiography in all but 3 
patients, in these three patients; the diagnosis is 
established by clinical finding of acute respiratory 
distress in the early post partum period with bilateral 
pulmonary crackles.  7 out of 10 (70%) pregnancies 
complicated by pulmonary edema occurred in women 
with NYHA class III and IV. so maternal morbidity in 
this study is slightly on higher side compare to other 
studies. 
 
Table 30: Authors with respect to their CCF and TE 
 
Author’s name and year                                                        CCF   TE 
Sawhney 2003 PGI Chandigarh               02.00% 0.80% 
Asghar 2005 Pakistan                                     21.20%                  2.00% 
D.Prathiba et al 2007 Hyderabad                      11.00%                   2.00% 
In present study 07.00% _Nil 
 
Fetal assessment by Apgar score:In this study 73%% 
babies had APGAR score above 8 at birth at 1 min. and 
15% babies had APGAR less than 4 at time of birth1 
min. At 5 min APGAR score only 3 babies had APGAR 
less than 4 and 60 babies (82%)had APGAR >8. Datta 
Ray Chaitali and coworker[40]  (2004) said that Apgar 
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at birth in both the groups was similar with means of 
8.81 in operated cases of heart disease and 8.45 non- 
 
operated cases of heart disease. 3 neonates 0ut of 14 
neonates (21.42%) had Apgar <4 in NYHA class III and 
IV as compare to NYHA class I and II which had 3 
neonates out of 54 neonates (5.55%) with Apgar < 4. 
Malhotra and colleagues [90] (2003) reported that 
perinatal outcome was more adverse in the valvular heart 
disease group than normal patients, which had higher 
incidence of APGAR scores less than 8 (8.3% vs. 4%).so 
neonatal outcome by APGAR score is four time better in 
NYHA class I/II as compare to NYHA class III/IV.  
Fetal assessment by weight: In this study mean 
birth weight of the babies was 2.54± 0.44 kg. Mean 
birth weight in NYHA classes I/II was 2.64± 0.44 
kg and mean birth weight in NYHA class III/IV 
was 2.34± 0.44 kg. Fetal assessment done by 
weight most of the babies 30.98% were from 2.1-
2.5 group.34 babies from low birth weight group.7 
babies from very low birth weight. 1 baby had 
extremely low birth weight infant (table no.21).N. 
Bhatla and colleagues [17] (2003) said that 
patients in NYHA class I/II (n=175, 84.54%) had 
fewer maternal complications and their babies had 
a higher birth weight than those in NYHA class 
III/IV (n=32, 15.45%). Datta Ray Chaitali and 
coworker [40] (2004) said that the mean birth 
weight of the babies of operated mothers for 
cardiac lesion was 2.72 ± 0.33 kg while that of the 
non-operated mothers for cardiac lesion was 2.53 ± 
0.44 kg.  
Neonatal morbidity: In this study out of 71 cases 
65 patients had given live birth to 68 babies in 
which three patients had twin pregnancy. Neonatal 
morbidity observed in 38 babies out of 68 neonates 
(55.88%). 35 babies were admitted in NICU after 
delivery (51.47%). 19 out of 68 live births were 
preterm (27.94%).6 babies were small for 
gestational age (08.82%). In 3 babies congenital 
anomaly were found, 1 baby had ectopia cardis and 
2 babies had ASD. So in study 2 mothers with 
congenital heart disease had offspring with 
congenital heart disease. 10 cases of meconium 
aspiration syndrome and RDS were seen. 4 cases 
from 71 had IUD in which 3 cases had IUD due to 
maternal mortality and 1 case IUD due to 
congenital anomaly to baby. So neonatal morbidity 
is in similar range with other Indian studies. In 
NICU admissions 8 babies had neonatal jaundice, 6 
babies had neonatal hypoglycemia and 5 neonates 
had neonatal sepsis. In this study neonatal 
morbidity was present in 30 out of 53 (56.60%) 
neonates of mother from NYHA class I and II. In 
NYHA class III and IV neonatal morbidity was 
present in 9 neonates out of 14 (64.28%) neonates. 
 
Table  31: Author with respect to number of cases,LBW,IUD and preterm 
 
Name and year No.  cases Preterm % LBW % IUD % 
Sawhney 2003 PGI Chandigarh 500 - - 2 
Hameed 2001 California  USA 66 21 21 2 
Asghar 2005 Pakistan 33 42.55 - - 
D.Prathiba et al 2007 Hyderabad 200 9.35 37.4 0.9  
              
 
Siu et al [90] (2001) in their prospective 
longitudinal study of pregnancy outcomes in women 
with heart disease reported neonatal outcomes in 
302 pregnancies. Neonatal complications occurred 
in 18% of pregnancies. Preterm delivery occurred in 
15%, fetal growth restriction in 4%, respiratory 
distress syndrome or intraventricular hemorrhage in 
2% and neonatal death in 3% of pregnancies. 
Predictors of adverse neonatal outcomes were 
NYHA class greater than II, cyanosis, maternal left 
ventricular obstruction, maternal smoking, maternal 
age under 20 years or over 35 years, multiple 
gestation and anticoagulation during pregnancy. N 
.Bhatla [17] 2003 said that a fetal complications 
seen in 42 (20.28%) pregnancies with heart disease. 
Doshi  HU [48] reported that there were more 
preterm babies (27.7%) and babies with intra-uterine 
growth restriction (48.9%) in pregnancy 
complicated by heart disease. Malhotra and 
colleagues [90] (2003) reported that perinatal 
outcome was also more adverse in the valvular heart 
disease group than in the control group, with 
increased preterm delivery rate (48.3% vs. 20.5%), 
reduced birth weight (2434±599 g vs. 2653±542 g), 
and a higher incidence of APGAR scores less than 8 
(8.3% vs. 4%). Sawhney and coworkers [112] 
(2003) described that the incidence of preterm birth 
and small for gestational age newborns was 12% 
and 18.2%, respectively.  
Maternal mortality: In this study maternal 
mortality was observed in 4 (5.63%) out of 71 
patients. Out of 4 patients 3 maternal mortality were 
occurred in antenatal period and in 1 after 4 hrs of 
delivery (Table No.23). Out of four maternal 
mortality cases 2 had sever mitral stenosis, 1 had 
ASD and 1 had PDA.  All 4 maternal mortality 
occurred in NYHA class III and class IV. All four 
patients had CCF with atrial fibrillation. This 
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maternal mortality were due to low socioeconomic 
status, illiteracy, lack of advance facility in grass 
root level, low living standards and ignorance 
towards female regarding health issue because out of 
four cases 2 were unregistered and 1 was registered 
outside and they admitted in hospital in stage of 
cardiac failure from where recovery of patients were 
difficult. Out of 3 antenatal mortality first case was  
unregistered gravida two with 20 wks pregnancy not 
in labor, with severe mitral stenosis in CCF, patient 
came in critical condition from where recovery were 
not possible. Second case was 34 wks primigravida 
with PDA with PHT with atrial flutter, she was 
registered with us and cardiologist advised her 
corrective surgery for it at higher center but patient 
not followed advice and medication results in 
maternal mortality. Triggering factor for CCF was 
URTI. Third patient was unregistered 24 wks 
gravida two admitted with severe mitral stenosis 
with CCF and atrial fibrillation, patient expired with 
in hour after admission. Fourth case was outside 
registered 34 wks gravida two with ASD with PHT 
admitted as case of severe anemia with 
breathlessness in latent labour. Due to anemia and 
stress of labour patient developed CCF during active 
labour and after forceps delivery in postpartum 
period patients CCF deteriorated and expired within 
4 hrs after delivery.  Sawhney and colleague[112] 
(2003) reported in their study10 (2.05%) maternal 
death of which 8(80%) patient were NYHA III-IV 
patients 
 
Table 32: Authors with respect to percentage of maternal mortality 
 
Author’s name and year  Percentage of maternal mortality 
M.malhotra and colleagues 2004                      [0.64%] 
Sawhney and colleagues 2003                   [2.05%] 
D.Prathiba   and colleagues2007                 [0.89%] 
In present study [5.63%} 
  
Neonatal mortality:  Neonatal mortality was seen 
in 5 neonates (7.35%) out of 68 neonates, all are 
due to preterm delivery. In neonatal mortality 3 
neonate’s mothers were from NYHA class III and 
IV .Paul Khairy and colleagues [49] (2004) stated 
neonatal mortality in 4.2% neonates. Wilem 
Drenthen and colleagues [79] said that neonatal 
mortality occurred in 2.3% neonates. So in present 
study neonatal and maternal mortality is slightly 
higher than other studies mentioned above.  
Contraceptive advice: During pre and post natal 
counseling, contraceptive advise given to all 
patients. Contraceptive advice was given to 67 
patients. Tubal ligation was done in 2 patients 
during LSCS.  Vasectomy advised to 5 patients due 
to maternal high risk cardiac status and high risk in 
operative procedure. Barrier contraceptive advised 
to 29 primigravida and IUCD advised to two 
patient of arrhythmia. In 13 patients tubectomy 
advised after six weeks of delivery or when she 
becomes hemodynamically stable for surgery and 
anesthesia.  
Preventive measures: As said that prevention is 
better than cure, to reduce maternal and neonatal 
morbidity and mortality preventive measure are 
must from beginning. To reduce prevalence of 
rheumatic heart disease in developing country 
proper management and timely treatment of 
rheumatic fever in school age group children is 
necessary.  For that regular interval school health 
check up and mass education regarding health care 
should be conducted. Early detection of heart 
disease patients in childhood is one of the 
important factor in preventive measure. It will 
prevent deterioration of heart condition if timely 
treatment or corrective surgery done in childhood 
only. Second most important preventive measure is 
preconceptional counseling. Preconceptional 
counseling will improve knowledge, attitude and 
behavior of men and women related to health. 
Women with severe heart disease will benefit 
immensely from counseling before deciding to 
become pregnant. In some women, life-threatening 
cardiac abnormalities can be reversed by corrective 
surgery, and subsequent pregnancy is less 
dangerous. All pregnancy with heart disease should 
be registered in tertiary health care center and 
100% hospital delivery of such patients will reduce 
maternal and neonatal mortality significantly. 
Lastly proper postnatal care of patient and neonates 
followed by contraception advice will reduce 
complication rate. The presence of adequate 
systems for early detection, appropriate referral to 
specialist centers, and timely delivery with 
multidisciplinary support can minimize the serious 
consequences of poorly controlled heart disease in 
pregnancy. So heart disease with pregnancy should 
be managed as team approach involving an 
obstetrician, cardiologist and anesthesiologist will 
improve maternal and neonatal outcome. So “100% 
antenatal registration, 100% diagnosis and 
treatment of lesion and 100% hospital delivery” are 
key factors for prevention of maternal and neonatal 
mortality and morbidity. 
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Conclusion 
In conclusion, heart disease in pregnancy is 
associated with significant maternal and perinatal 
morbidity in NYHA class III/IV patients. 
Rheumatic heart disease was the predominant type. 
Patients in NYHA class I/II had a better maternal 
and fetal outcome than those in NYHA class III/IV. 
Surgical correction of the cardiac lesion prior to 
pregnancy was associated with better pregnancy 
outcome.  Pregnancy in women with heart disease 
is associated with significantly higher maternal 
morbidity and adverse fetal outcomes and requires 
a team approach for optimal management.  
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Table 33: List of abbreviations used 
 
1 ACC 
/AHA 
American College of Cardiology 
/American heart association. 
18 NYHA New York Heart Association. 
 
2 AF Atrial fibrillation 
 
19 PAH pulmonary arterial hypertension 
 
3 AR  Aortic insufficiency 
 
20 PDA  Persistent ductus arteriosus. 
 
4 AS Aortic stenosis 
 
21 PIH Pregnancy induced hypertension. 
 
5 ASD Atrial septal defect 
 
22 PVR Peripheral vascular resistance. 
 
6 CCF  Congestive cardiac failure. 
 
23 RBBB Right bundle branch block 
 
7 CHD congenital heart disease 
 
24 RF Rheumatic Fever 
 
8 ECG Electrocardiogram 
 
25 RHD Rheumatic heart disease 
 
9 INR International normalized ratio 
 
26 RV Right ventricle 
 
10 IUD  Intrauterine death. 
 
27 SVT Supraventricular Tachycardia 
 
11 IUGR Intrauterine growth retardation. 
 
28 TOF Tetrology of fallot. 
 
12 LMWH  Low molecular weight Heparin 
 
29 UFH Unfractionated heparin 
 
13 LSCS Lower segment cesarean section 
 
30 URTI Upper respiratory tract infection. 
 
14 LV  Left ventricle 
 
31 VSD Ventricular septal defect 
 
15 MR Mitral insufficiency 
 
32 WHO World health organization. 
 
16 MVP Mitral valve prolapse 
 
33 WPW Wolff-Parkinson-White syndrome 
 
17 NICU Neonatal intensive care unit 
 
34 LVH Left ventricular hypertrophy 
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